To evaluate the Safety and efficacy of Unani formulations in the treatment of Hepatitis
Phase 2
- Conditions
- Health Condition 1: B179- Acute viral hepatitis, unspecifiedHealth Condition 2: null- Warm e Kabid (Hepatitis)
- Registration Number
- CTRI/2013/12/004184
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 55
Inclusion Criteria
1)Patients of both sexes between 18 to 60 yrs.
2)Patients having laboratory features of Warm e Kabid (Hepatitis) (Bilirubin >= 3 mg% and SGPT >= 100 IU/L of serum.)
3)Presence of any of the following clinical features
1.Heat in hepatic region
2.Heaviness in hepatic region
3.Dislike of oily food ,Strong aversion for food (Nausea),
4.Indigestion
5.Vomiting
6.Fever
7.Severe thirst
8.Constipation
9.Itching
10.Loss of weight
11.Fatigue
12.High colored urine
13.Jaundice
Exclusion Criteria
1)History or clinical evidence of cirrhosis of liver
2)Obstructive / Hemolytic Jaundice
3)Diseases / disorders requiring long term treatment
4)Drug addicts ( Alcohol, drugs )
5)Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptomsTimepoint: 8 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method Hematological, microbiological and biochemical assessments for safetyTimepoint: 8 weeks